Dr. Daniel A. King
Claim this profileNorthwell Health/Center for Advanced Medicine
Studies Pancreatic Cancer
Studies Stomach Cancer
4 reported clinical trials
7 drugs studied
Area of expertise
1Pancreatic Cancer
Stage IV
BRCA1 positive
BRCA2 positive
2Stomach Cancer
CLDN18.2 positive
Affiliated Hospitals
Clinical Trials Daniel A. King is currently running
Olaparib
for Pancreatic Cancer
This phase II trial investigates how well the addition of olaparib following completion of surgery and chemotherapy works in treating patients with pancreatic cancer that has been surgically removed (resected) and has a pathogenic mutation in BRCA1, BRCA2, or PALB2. Olaparib is an inhibitor of PARP, an enzyme that helps repair deoxyribonucleic acid (DNA) when it becomes damaged. Blocking PARP may help keep tumor cells from repairing their damaged DNA, causing them to die. PARP inhibitors are a type of targeted therapy.
Recruiting0 awards Phase 232 criteria
PBP1510 + Gemcitabine
for Pancreatic Cancer
This trial is testing a new drug called PBP1510, alone or with gemcitabine, in patients with advanced pancreatic cancer that hasn't responded to previous treatments. The goal is to see if PBP1510 can help stop or slow down the growth of their tumors. Gemcitabine has been a standard treatment for advanced pancreatic cancer, often used alone or in combination with other drugs to improve efficacy.
Recruiting1 award Phase 1 & 219 criteria
More about Daniel A. King
Clinical Trial Related3 years of experience running clinical trials · Led 4 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Daniel A. King has experience with
- Gemcitabine
- CT041
- Olaparib
- Nab-paclitaxel
- Liposomal Irinotecan
- Fluorouracil
Breakdown of trials Daniel A. King has run
Pancreatic Cancer
Stomach Cancer
Adenocarcinoma
Adenosquamous Carcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Daniel A. King specialize in?
Daniel A. King focuses on Pancreatic Cancer and Stomach Cancer. In particular, much of their work with Pancreatic Cancer has involved Stage IV patients, or patients who are BRCA1 positive.
Is Daniel A. King currently recruiting for clinical trials?
Yes, Daniel A. King is currently recruiting for 2 clinical trials in Lake Success New York. If you're interested in participating, you should apply.
Are there any treatments that Daniel A. King has studied deeply?
Yes, Daniel A. King has studied treatments such as Gemcitabine, CT041, Olaparib.
What is the best way to schedule an appointment with Daniel A. King?
Apply for one of the trials that Daniel A. King is conducting.
What is the office address of Daniel A. King?
The office of Daniel A. King is located at: Northwell Health/Center for Advanced Medicine, Lake Success, New York 11042 United States. This is the address for their practice at the Northwell Health/Center for Advanced Medicine.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.